BioNTech SE SEC filings BNTX
BioNTech SE has 589 filings in SEC EDGAR's recent list, going back to Jun 19, 2019. Its latest annual report, Form 20-F, was filed on Mar 10, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 3, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Nov 3, 2026 | Sep 30, 2026 |
| 6-K | Current report (foreign issuer) | Nov 3, 2026 | Nov 3, 2026 |
| 6-K | Current report (foreign issuer) | Oct 26, 2026 | Oct 26, 2026 |
| 6-K | Current report (foreign issuer) | Oct 26, 2026 | Oct 26, 2026 |
| 6-K | Current report (foreign issuer) | Oct 22, 2026 | Oct 22, 2026 |
| 6-K | Current report (foreign issuer) | Oct 19, 2026 | Oct 19, 2026 |
| 6-K | Current report (foreign issuer) | Oct 13, 2026 | Oct 13, 2026 |
| 6-K | Current report (foreign issuer) | Sep 18, 2026 | Sep 18, 2026 |
| 6-K | Current report (foreign issuer) | Sep 14, 2026 | Sep 14, 2026 |
| 6-K | Current report (foreign issuer) | Aug 28, 2026 | Aug 28, 2026 |
| 6-K | Current report (foreign issuer) | Aug 27, 2026 | Aug 27, 2026 |
| 6-K | Current report (foreign issuer) | Aug 20, 2026 | Aug 20, 2026 |
| 6-K | Current report (foreign issuer) | Aug 4, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Aug 4, 2026 | Aug 4, 2026 |
| 6-K | Current report (foreign issuer) | Aug 3, 2026 | Aug 3, 2026 |
| 20-F/A | Amended annual report (foreign issuer) | Jul 30, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Jul 29, 2026 | Jul 29, 2026 |
| 6-K | Current report (foreign issuer) | Jun 8, 2026 | Jun 8, 2026 |
| 6-K | Current report (foreign issuer) | Jun 1, 2026 | Jun 1, 2026 |
| 6-K | Current report (foreign issuer) | May 22, 2026 | May 22, 2026 |
| 6-K | Current report (foreign issuer) | May 15, 2026 | May 15, 2026 |
| 6-K | Current report (foreign issuer) | May 7, 2026 | May 7, 2026 |
| 6-K | Current report (foreign issuer) | May 5, 2026 | Mar 31, 2026 |
| 6-K | Current report (foreign issuer) | May 5, 2026 | May 5, 2026 |
| 6-K | Current report (foreign issuer) | Apr 13, 2026 | Apr 13, 2026 |
| 6-K | Current report (foreign issuer) | Apr 2, 2026 | Apr 2, 2026 |
| 20-F/A | Amended annual report (foreign issuer) | Apr 1, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Mar 24, 2026 | Mar 24, 2026 |
| 20-F | Annual report (foreign issuer) | Mar 10, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Mar 10, 2026 | Mar 10, 2026 |
| 6-K | Current report (foreign issuer) | Mar 10, 2026 | Mar 10, 2026 |
| 6-K | Current report (foreign issuer) | Jan 28, 2026 | Jan 28, 2026 |
| 6-K | Current report (foreign issuer) | Jan 14, 2026 | Jan 13, 2026 |
| 6-K | Current report (foreign issuer) | Jan 12, 2026 | Jan 12, 2026 |
| 6-K | Current report (foreign issuer) | Jan 6, 2026 | Jan 6, 2026 |
| SC TO-T/A | Filing | Dec 18, 2025 | — |
| 6-K | Current report (foreign issuer) | Dec 18, 2025 | Dec 18, 2025 |
| 6-K | Current report (foreign issuer) | Dec 9, 2025 | Dec 9, 2025 |
| 6-K | Current report (foreign issuer) | Dec 8, 2025 | Dec 6, 2025 |
| SC TO-T/A | Filing | Dec 3, 2025 | — |
| 425 | Filing | Dec 3, 2025 | — |
| 6-K | Current report (foreign issuer) | Dec 3, 2025 | Dec 3, 2025 |
| SC TO-T/A | Filing | Nov 26, 2025 | — |
| 425 | Filing | Nov 26, 2025 | — |
| 6-K | Current report (foreign issuer) | Nov 26, 2025 | Nov 26, 2025 |
| 424B3 | Prospectus | Nov 14, 2025 | — |
| 425 | Filing | Nov 12, 2025 | — |
| 425 | Filing | Nov 12, 2025 | — |
| 6-K | Current report (foreign issuer) | Nov 12, 2025 | Nov 12, 2025 |
| 6-K | Current report (foreign issuer) | Nov 3, 2025 | Sep 30, 2025 |
| 6-K | Current report (foreign issuer) | Nov 3, 2025 | Nov 3, 2025 |
| SC TO-T/A | Filing | Oct 22, 2025 | — |
| 425 | Filing | Oct 22, 2025 | — |
| 425 | Filing | Oct 22, 2025 | — |
| 6-K | Current report (foreign issuer) | Oct 22, 2025 | Oct 22, 2025 |
| SC TO-T | Filing | Oct 21, 2025 | — |
| F-4/A | Filing | Oct 21, 2025 | — |
| 425 | Filing | Oct 20, 2025 | — |
| 425 | Filing | Oct 20, 2025 | — |
| 6-K | Current report (foreign issuer) | Oct 1, 2025 | Oct 1, 2025 |
| 6-K | Current report (foreign issuer) | Sep 8, 2025 | Sep 8, 2025 |
| CORRESP | Letter to the SEC | Sep 8, 2025 | — |
| F-4/A | Filing | Sep 8, 2025 | — |
| 6-K | Current report (foreign issuer) | Sep 8, 2025 | Sep 8, 2025 |
| 6-K | Current report (foreign issuer) | Sep 5, 2025 | Sep 5, 2025 |
| 6-K | Current report (foreign issuer) | Aug 27, 2025 | Aug 27, 2025 |
| UPLOAD | Letter from the SEC | Aug 12, 2025 | — |
| CORRESP | Letter to the SEC | Aug 11, 2025 | — |
| F-4 | Filing | Aug 11, 2025 | — |
| 425 | Filing | Aug 11, 2025 | — |
| 6-K | Current report (foreign issuer) | Aug 11, 2025 | Aug 11, 2025 |
| 425 | Filing | Aug 8, 2025 | — |
| 6-K | Current report (foreign issuer) | Aug 4, 2025 | Jun 30, 2025 |
| 6-K | Current report (foreign issuer) | Aug 4, 2025 | Aug 4, 2025 |
| 6-K | Current report (foreign issuer) | Jul 25, 2025 | Jul 25, 2025 |
| UPLOAD | Letter from the SEC | Jul 23, 2025 | — |
| 6-K | Current report (foreign issuer) | Jul 17, 2025 | Jul 17, 2025 |
| DRSLTR | Filing | Jun 30, 2025 | — |
| DRS | Filing | Jun 30, 2025 | — |
| 6-K | Current report (foreign issuer) | Jun 17, 2025 | Jun 17, 2025 |
| 425 | Filing | Jun 17, 2025 | — |
| 6-K | Current report (foreign issuer) | Jun 17, 2025 | Jun 17, 2025 |
| 425 | Filing | Jun 12, 2025 | — |
| 425 | Filing | Jun 12, 2025 | — |
| 425 | Filing | Jun 12, 2025 | — |
| 425 | Filing | Jun 12, 2025 | — |
| 425 | Filing | Jun 12, 2025 | — |
| 6-K | Current report (foreign issuer) | Jun 12, 2025 | Jun 12, 2025 |
| 6-K | Current report (foreign issuer) | Jun 2, 2025 | Jun 2, 2025 |
| 6-K | Current report (foreign issuer) | May 27, 2025 | May 27, 2025 |
| 6-K | Current report (foreign issuer) | May 20, 2025 | May 20, 2025 |
| 6-K | Current report (foreign issuer) | May 16, 2025 | May 16, 2025 |
| 6-K | Current report (foreign issuer) | May 5, 2025 | May 5, 2025 |
| 6-K | Current report (foreign issuer) | May 5, 2025 | May 5, 2025 |
| 6-K | Current report (foreign issuer) | May 5, 2025 | May 5, 2025 |
| 6-K | Current report (foreign issuer) | Apr 24, 2025 | Apr 24, 2025 |
| 6-K | Current report (foreign issuer) | Apr 4, 2025 | Apr 4, 2025 |
| 6-K | Current report (foreign issuer) | Apr 2, 2025 | Apr 2, 2025 |
| 20-F | Annual report (foreign issuer) | Mar 10, 2025 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | Mar 10, 2025 | Mar 10, 2025 |
| 6-K | Current report (foreign issuer) | Mar 4, 2025 | Mar 4, 2025 |
| 6-K | Current report (foreign issuer) | Feb 3, 2025 | Feb 3, 2025 |
| 6-K | Current report (foreign issuer) | Jan 14, 2025 | Jan 14, 2025 |
| 6-K | Current report (foreign issuer) | Dec 27, 2024 | Dec 27, 2024 |
| 6-K | Current report (foreign issuer) | Dec 27, 2024 | Dec 27, 2024 |
| 6-K | Current report (foreign issuer) | Dec 13, 2024 | Dec 13, 2024 |
| 6-K | Current report (foreign issuer) | Nov 14, 2024 | Nov 14, 2024 |
| 6-K | Current report (foreign issuer) | Nov 13, 2024 | Nov 13, 2024 |
| 6-K | Current report (foreign issuer) | Nov 4, 2024 | Sep 30, 2024 |
| 6-K | Current report (foreign issuer) | Nov 4, 2024 | Nov 4, 2024 |
| 6-K | Current report (foreign issuer) | Oct 18, 2024 | Oct 18, 2024 |
| 6-K | Current report (foreign issuer) | Oct 1, 2024 | Oct 1, 2024 |
| 6-K | Current report (foreign issuer) | Sep 20, 2024 | Sep 20, 2024 |
| 6-K | Current report (foreign issuer) | Sep 5, 2024 | Sep 5, 2024 |
| 6-K | Current report (foreign issuer) | Aug 22, 2024 | Aug 22, 2024 |
| 6-K | Current report (foreign issuer) | Aug 19, 2024 | Aug 19, 2024 |
| 6-K | Current report (foreign issuer) | Aug 16, 2024 | Aug 16, 2024 |
| 6-K | Current report (foreign issuer) | Aug 7, 2024 | Aug 6, 2024 |
| 6-K | Current report (foreign issuer) | Aug 5, 2024 | Jun 30, 2024 |
| 6-K | Current report (foreign issuer) | Aug 5, 2024 | Aug 5, 2024 |
| 6-K | Current report (foreign issuer) | Jul 30, 2024 | Jul 30, 2024 |
| 6-K | Current report (foreign issuer) | Jun 28, 2024 | Jun 27, 2024 |
| 6-K | Current report (foreign issuer) | Jun 24, 2024 | Jun 24, 2024 |
| 6-K | Current report (foreign issuer) | Jun 17, 2024 | Jun 17, 2024 |
| 6-K | Current report (foreign issuer) | Jun 3, 2024 | Jun 3, 2024 |
| 6-K | Current report (foreign issuer) | May 30, 2024 | May 29, 2024 |
| 6-K | Current report (foreign issuer) | May 21, 2024 | May 21, 2024 |
| 6-K | Current report (foreign issuer) | May 17, 2024 | May 17, 2024 |
| 6-K | Current report (foreign issuer) | May 6, 2024 | Mar 31, 2024 |
| 6-K | Current report (foreign issuer) | May 6, 2024 | May 6, 2024 |
| 6-K | Current report (foreign issuer) | Apr 8, 2024 | Apr 8, 2024 |
| 6-K | Current report (foreign issuer) | Apr 8, 2024 | Apr 8, 2024 |
| 6-K | Current report (foreign issuer) | Mar 25, 2024 | Mar 22, 2024 |
| 20-F | Annual report (foreign issuer) | Mar 20, 2024 | Dec 31, 2023 |
| 6-K | Current report (foreign issuer) | Mar 20, 2024 | Mar 20, 2024 |
| 6-K | Current report (foreign issuer) | Mar 20, 2024 | Mar 20, 2024 |
| 6-K | Current report (foreign issuer) | Mar 11, 2024 | Mar 11, 2024 |
| 6-K | Current report (foreign issuer) | Mar 7, 2024 | Mar 7, 2024 |
| S-8 | Employee stock plan registration | Feb 15, 2024 | — |
| 6-K | Current report (foreign issuer) | Feb 8, 2024 | Feb 8, 2024 |
| 6-K | Current report (foreign issuer) | Jan 31, 2024 | Jan 31, 2024 |
| 6-K | Current report (foreign issuer) | Jan 22, 2024 | Jan 22, 2024 |
| 6-K | Current report (foreign issuer) | Jan 9, 2024 | Jan 9, 2024 |
| 6-K | Current report (foreign issuer) | Dec 21, 2023 | Dec 21, 2023 |
| 6-K | Current report (foreign issuer) | Dec 18, 2023 | Dec 18, 2023 |
| 6-K | Current report (foreign issuer) | Dec 8, 2023 | Dec 8, 2023 |
| 6-K | Current report (foreign issuer) | Nov 7, 2023 | Nov 7, 2023 |
| 6-K | Current report (foreign issuer) | Nov 6, 2023 | Sep 30, 2023 |
| 6-K | Current report (foreign issuer) | Nov 6, 2023 | Nov 6, 2023 |
| 6-K | Current report (foreign issuer) | Oct 26, 2023 | Oct 26, 2023 |
| 6-K | Current report (foreign issuer) | Oct 23, 2023 | Oct 23, 2023 |
| 6-K | Current report (foreign issuer) | Oct 16, 2023 | Oct 16, 2023 |
| 6-K | Current report (foreign issuer) | Oct 16, 2023 | Oct 16, 2023 |
| 6-K | Current report (foreign issuer) | Sep 11, 2023 | Sep 11, 2023 |
| 6-K | Current report (foreign issuer) | Aug 30, 2023 | Aug 30, 2023 |
| 6-K | Current report (foreign issuer) | Aug 14, 2023 | Aug 14, 2023 |
| 6-K | Current report (foreign issuer) | Aug 7, 2023 | Jun 30, 2023 |
| 6-K | Current report (foreign issuer) | Aug 7, 2023 | Aug 7, 2023 |
| 6-K | Current report (foreign issuer) | Jul 31, 2023 | Jul 31, 2023 |
| 6-K | Current report (foreign issuer) | Jun 29, 2023 | Jun 29, 2023 |
| 6-K | Current report (foreign issuer) | Jun 26, 2023 | Jun 26, 2023 |
| 6-K | Current report (foreign issuer) | Jun 23, 2023 | Jun 23, 2023 |
| 6-K | Current report (foreign issuer) | Jun 2, 2023 | Jun 2, 2023 |
| 6-K | Current report (foreign issuer) | Jun 2, 2023 | Jun 2, 2023 |
| 6-K | Current report (foreign issuer) | May 26, 2023 | May 26, 2023 |
| 6-K | Current report (foreign issuer) | May 25, 2023 | May 25, 2023 |
| 6-K | Current report (foreign issuer) | May 8, 2023 | Mar 31, 2023 |
| 6-K | Current report (foreign issuer) | May 8, 2023 | Mar 31, 2023 |
| 6-K | Current report (foreign issuer) | May 8, 2023 | May 8, 2023 |
| 6-K | Current report (foreign issuer) | Apr 13, 2023 | Apr 13, 2023 |
| 6-K | Current report (foreign issuer) | Apr 3, 2023 | Apr 3, 2023 |
| 6-K | Current report (foreign issuer) | Mar 28, 2023 | Mar 27, 2023 |
| 20-F | Annual report (foreign issuer) | Mar 27, 2023 | Dec 31, 2022 |
| 6-K | Current report (foreign issuer) | Mar 27, 2023 | Mar 27, 2023 |
| 6-K | Current report (foreign issuer) | Mar 20, 2023 | Mar 20, 2023 |
| 6-K | Current report (foreign issuer) | Mar 15, 2023 | Mar 14, 2023 |
| 6-K | Current report (foreign issuer) | Mar 1, 2023 | Mar 1, 2023 |
| 6-K | Current report (foreign issuer) | Feb 24, 2023 | Feb 24, 2023 |
| S-8 | Employee stock plan registration | Feb 13, 2023 | — |
| S-8 POS | Filing | Feb 13, 2023 | — |
| 6-K | Current report (foreign issuer) | Jan 10, 2023 | Jan 10, 2023 |
| 6-K | Current report (foreign issuer) | Jan 10, 2023 | Jan 31, 2023 |
| 6-K | Current report (foreign issuer) | Dec 22, 2022 | Dec 31, 2022 |
| 6-K | Current report (foreign issuer) | Dec 9, 2022 | Dec 9, 2022 |
| 6-K | Current report (foreign issuer) | Dec 8, 2022 | Dec 8, 2022 |
| 6-K | Current report (foreign issuer) | Dec 8, 2022 | Dec 7, 2022 |
| 6-K | Current report (foreign issuer) | Dec 5, 2022 | Dec 5, 2022 |
| 6-K | Current report (foreign issuer) | Nov 30, 2022 | Nov 30, 2022 |
| 6-K | Current report (foreign issuer) | Nov 18, 2022 | Nov 18, 2022 |
| 6-K | Current report (foreign issuer) | Nov 17, 2022 | Nov 17, 2022 |
| 6-K | Current report (foreign issuer) | Nov 10, 2022 | Nov 10, 2022 |
| 6-K | Current report (foreign issuer) | Nov 10, 2022 | Nov 10, 2022 |
| 6-K | Current report (foreign issuer) | Nov 7, 2022 | Sep 30, 2022 |
| 6-K | Current report (foreign issuer) | Nov 7, 2022 | Nov 7, 2022 |
| 6-K | Current report (foreign issuer) | Nov 4, 2022 | Nov 4, 2022 |
| 20-F/A | Amended annual report (foreign issuer) | Oct 26, 2022 | Dec 31, 2021 |
| 6-K | Current report (foreign issuer) | Oct 20, 2022 | Oct 19, 2022 |
| 6-K | Current report (foreign issuer) | Oct 14, 2022 | Oct 13, 2022 |
| 6-K | Current report (foreign issuer) | Oct 12, 2022 | Oct 12, 2022 |
| 6-K | Current report (foreign issuer) | Sep 26, 2022 | Sep 26, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- BNTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Germany
- Headquarters
- Mainz, Germany
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1776985
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- Exelixis, Inc. EXEL
- Neurocrine Biosciences Inc NBIX
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.